Pharmacological studies on the subcellular site of action of botulinum toxin type A.
D000631:Aminopyridines / Q000494:pharmacology; D000818:Animals; D001496:Batrachotoxins / Q000494:pharmacology; D001740:Black Widow Spider; D001905:Botulinum Toxins / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D066298:In Vitro Techniques; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D013111:Spider Venoms / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*
D000631:Aminopyridines; D001496:Batrachotoxins; D013111:Spider Venoms; D001905:Botulinum Toxins; D008274:Magnesium; D011188:Potassium; D002118:Calcium